Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Interstitial Lung Disease
- Pulmonary Fibrosis
- Rheumatoid Arthritis
- Rheumatoid Lung
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
BERTHA is a multicentric, observational study that will enroll 100 RA-ILD patients to be followed for 2 years. Interstitial Lung Disease (ILD) progression will be ascertained by quantitative image analysis and functional parameters. Variables associated with progression with be identified. Additiona...
BERTHA is a multicentric, observational study that will enroll 100 RA-ILD patients to be followed for 2 years. Interstitial Lung Disease (ILD) progression will be ascertained by quantitative image analysis and functional parameters. Variables associated with progression with be identified. Additionally, RA-ILD endotypes will be investigated as well as their association with RA-ILD progression.
Tracking Information
- NCT #
- NCT04136223
- Collaborators
- Bristol-Myers Squibb
- DASA
- Investigators
- Study Chair: Alexandra Latini, MSc Federal University of Santa Catarina
Get Well Soon